Juergens RA - Search Results

1

Current and Future Treatment Options in the Management of Stage III NSCLC.

Li Y, Juergens RA, Finley C, Swaminath A. Li Y, et al. Among authors: juergens ra. J Thorac Oncol. 2023 Nov;18(11):1478-1491. doi: 10.1016/j.jtho.2023.08.011. Epub 2023 Aug 11. J Thorac Oncol. 2023. PMID: 37574133 Review.

2

Multidisciplinary Influence on Care of Lung Cancer Patients at the Time of Diagnosis: a Patient Survey.

Yiu KC, Juergens RA, Swaminath A. Yiu KC, et al. Among authors: juergens ra. Clin Oncol (R Coll Radiol). 2016 Oct;28(10):667. doi: 10.1016/j.clon.2016.04.046. Epub 2016 May 24. Clin Oncol (R Coll Radiol). 2016. PMID: 27235380 No abstract available.

3

A Novel Neoadjuvant Therapy for Operable Locally Invasive Non-Small-Cell Lung Cancer. Phase I Study of Neoadjuvant Stereotactic Body Radiotherapy. LINNEARRE I (NCT02433574).

Nguyen NA, Isfahanian N, Pond G, Hanna W, Cutz JC, Wright J, Swaminath A, Shargall Y, Chow T, Wierzbicki M, Okawara G, Quan K, Finley C, Juergens R, Tsakiridis T. Nguyen NA, et al. Clin Lung Cancer. 2017 Jul;18(4):436-440.e1. doi: 10.1016/j.cllc.2017.01.007. Epub 2017 Jan 31. Clin Lung Cancer. 2017. PMID: 28215851 Clinical Trial.

4

Update on Programmed Death-1 and Programmed Death-Ligand 1 Inhibition in the Treatment of Advanced or Metastatic Non-Small Cell Lung Cancer.

Iafolla MAJ, Juergens RA. Iafolla MAJ, et al. Among authors: juergens ra. Front Oncol. 2017 Apr 6;7:67. doi: 10.3389/fonc.2017.00067. eCollection 2017. Front Oncol. 2017. PMID: 28428947 Free PMC article. Review.

5

Nivolumab Plus Erlotinib in Patients With EGFR-Mutant Advanced NSCLC.

Gettinger S, Hellmann MD, Chow LQM, Borghaei H, Antonia S, Brahmer JR, Goldman JW, Gerber DE, Juergens RA, Shepherd FA, Laurie SA, Young TC, Li X, Geese WJ, Rizvi N. Gettinger S, et al. Among authors: juergens ra. J Thorac Oncol. 2018 Sep;13(9):1363-1372. doi: 10.1016/j.jtho.2018.05.015. Epub 2018 May 23. J Thorac Oncol. 2018. PMID: 29802888 Free article. Clinical Trial.

6

Immune checkpoint-inhibitors and chemoradiation in stage III unresectable non-small cell lung cancer.

Melosky B, Juergens R, McLeod D, Leighl N, Brade A, Card PB, Chu Q. Melosky B, et al. Lung Cancer. 2019 Aug;134:259-267. doi: 10.1016/j.lungcan.2019.05.027. Epub 2019 May 29. Lung Cancer. 2019. PMID: 31319991 Review.

7

Evolution of anatomic pathology workload from 2011 to 2019 assessed in a regional hospital laboratory via 574,093 pathology reports.

Bonert M, Zafar U, Maung R, El-Shinnawy I, Kak I, Cutz JC, Naqvi A, Juergens RA, Finley C, Salama S, Major P, Kapoor A. Bonert M, et al. Among authors: juergens ra. PLoS One. 2021 Jun 29;16(6):e0253876. doi: 10.1371/journal.pone.0253876. eCollection 2021. PLoS One. 2021. PMID: 34185808 Free PMC article.

8

The rapidly evolving landscape of novel targeted therapies in advanced non-small cell lung cancer.

Melosky B, Wheatley-Price P, Juergens RA, Sacher A, Leighl NB, Tsao MS, Cheema P, Snow S, Liu G, Card PB, Chu Q. Melosky B, et al. Among authors: juergens ra. Lung Cancer. 2021 Oct;160:136-151. doi: 10.1016/j.lungcan.2021.06.002. Epub 2021 Jun 5. Lung Cancer. 2021. PMID: 34353680 Review.

9

Role of Adjuvant Therapy in Esophageal Cancer Patients After Neoadjuvant Therapy and Esophagectomy: A Systematic Review and Meta-analysis.

Lee Y, Samarasinghe Y, Lee MH, Thiru L, Shargall Y, Finley C, Hanna W, Levine O, Juergens R, Agzarian J. Lee Y, et al. Ann Surg. 2022 Jan 1;275(1):91-98. doi: 10.1097/SLA.0000000000005227. Ann Surg. 2022. PMID: 34596073

10

[No title available]

[No authors listed] [No authors listed] PMID: 34701548

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

80 results

Search Page